Ecor1-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
44
Total Value
1618567932
Accession Number
0000935836-25-000338
Form Type
13F-HR
Manager Name
Ecor1-Capital
Data Enrichment
93% identified
41 identified3 unidentified

Holdings

44 positions
Manager:
Search and click to pin securities to the top
Page 1 of 3
Apellis Pharmaceuticals, Inc.
Shares:11.9M
Value:$260.2M
Jazz Pharmaceuticals plc
Shares:1.7M
Value:$211.9M
Zymeworks Inc.
Shares:17.3M
Value:$205.6M
ANAPTYSBIO, INC
Shares:7.9M
Value:$146.5M
Crinetics Pharmaceuticals, Inc.
Shares:4.3M
Value:$143.8M
PROTHENA CORP PUBLIC LTD CO
Shares:11.6M
Value:$143.4M
Sarepta Therapeutics, Inc.
Shares:1.3M
Value:$82.5M
Xencor Inc
Shares:6.1M
Value:$65.4M
CRISPR Therapeutics AG
Shares:1.4M
Value:$47.3M
Janux Therapeutics, Inc.
Shares:1.5M
Value:$39.7M
Immunome Inc.
Shares:4.1M
Value:$27.5M
MADRIGAL PHARMACEUTICALS, INC.
Shares:75.0K
Value:$24.8M
Oric Pharmaceuticals, Inc.
Shares:3.4M
Value:$19.1M
Akero Therapeutics, Inc.
Shares:440.0K
Value:$17.8M
Kura Oncology, Inc.
Shares:2.6M
Value:$17.4M
Tectonic Therapeutic, Inc.
Shares:935.1K
Value:$16.6M
Avidity Biosciences, Inc.
Shares:557.6K
Value:$16.5M
Neurogene Inc.
Shares:1.3M
Value:$14.9M
Tango Therapeutics, Inc.
Shares:10.6M
Value:$14.6M
Voyager Therapeutics, Inc.
Shares:3.9M
Value:$13.2M